chr12-21558177-G-C
Variant names: 
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_021957.4(GYS2):c.1422+23C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.774 in 1,321,506 control chromosomes in the GnomAD database, including 398,444 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
 Genomes: 𝑓 0.72   (  40451   hom.,  cov: 31) 
 Exomes 𝑓:  0.78   (  357993   hom.  ) 
Consequence
 GYS2
NM_021957.4 intron
NM_021957.4 intron
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -1.56  
Publications
10 publications found 
Genes affected
 GYS2  (HGNC:4707):  (glycogen synthase 2) The protein encoded by this gene, liver glycogen synthase, catalyzes the rate-limiting step in the synthesis of glycogen - the transfer of a glucose molecule from UDP-glucose to a terminal branch of the glycogen molecule. Mutations in this gene cause glycogen storage disease type 0 (GSD-0) - a rare type of early childhood fasting hypoglycemia with decreased liver glycogen content. [provided by RefSeq, Dec 2009] 
GYS2 Gene-Disease associations (from GenCC):
- glycogen storage disorder due to hepatic glycogen synthase deficiencyInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, PanelApp Australia, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96). 
BP6
Variant 12-21558177-G-C is Benign according to our data. Variant chr12-21558177-G-C is described in ClinVar as Benign. ClinVar VariationId is 261466.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.777  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| GYS2 | NM_021957.4  | c.1422+23C>G | intron_variant | Intron 11 of 15 | ENST00000261195.3 | NP_068776.2 | ||
| GYS2 | XM_024448960.2  | c.1422+23C>G | intron_variant | Intron 11 of 16 | XP_024304728.1 | |||
| GYS2 | XM_006719063.4  | c.1191+23C>G | intron_variant | Intron 10 of 14 | XP_006719126.1 | 
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| GYS2 | ENST00000261195.3  | c.1422+23C>G | intron_variant | Intron 11 of 15 | 1 | NM_021957.4 | ENSP00000261195.2 | |||
| ENSG00000285854 | ENST00000647960.1  | n.*1424+23C>G | intron_variant | Intron 18 of 22 | ENSP00000497202.1 | |||||
| ENSG00000285854 | ENST00000648372.1  | n.1372C>G | non_coding_transcript_exon_variant | Exon 11 of 11 | 
Frequencies
GnomAD3 genomes   AF:  0.725  AC: 110049AN: 151870Hom.:  40414  Cov.: 31 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
110049
AN: 
151870
Hom.: 
Cov.: 
31
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.765  AC: 191420AN: 250296 AF XY:  0.767   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
191420
AN: 
250296
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.781  AC: 913207AN: 1169518Hom.:  357993  Cov.: 16 AF XY:  0.781  AC XY: 465427AN XY: 595964 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
913207
AN: 
1169518
Hom.: 
Cov.: 
16
 AF XY: 
AC XY: 
465427
AN XY: 
595964
show subpopulations 
African (AFR) 
 AF: 
AC: 
16641
AN: 
27994
American (AMR) 
 AF: 
AC: 
34549
AN: 
44286
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
16850
AN: 
24316
East Asian (EAS) 
 AF: 
AC: 
30090
AN: 
38270
South Asian (SAS) 
 AF: 
AC: 
63520
AN: 
80252
European-Finnish (FIN) 
 AF: 
AC: 
42846
AN: 
53284
Middle Eastern (MID) 
 AF: 
AC: 
3301
AN: 
5218
European-Non Finnish (NFE) 
 AF: 
AC: 
667483
AN: 
845208
Other (OTH) 
 AF: 
AC: 
37927
AN: 
50690
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.492 
Heterozygous variant carriers
 0 
 9733 
 19466 
 29200 
 38933 
 48666 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 13926 
 27852 
 41778 
 55704 
 69630 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome   AF:  0.725  AC: 110142AN: 151988Hom.:  40451  Cov.: 31 AF XY:  0.729  AC XY: 54130AN XY: 74288 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
110142
AN: 
151988
Hom.: 
Cov.: 
31
 AF XY: 
AC XY: 
54130
AN XY: 
74288
show subpopulations 
African (AFR) 
 AF: 
AC: 
24940
AN: 
41410
American (AMR) 
 AF: 
AC: 
11202
AN: 
15274
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
2388
AN: 
3468
East Asian (EAS) 
 AF: 
AC: 
3870
AN: 
5152
South Asian (SAS) 
 AF: 
AC: 
3828
AN: 
4814
European-Finnish (FIN) 
 AF: 
AC: 
8550
AN: 
10558
Middle Eastern (MID) 
 AF: 
AC: 
180
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
53197
AN: 
67998
Other (OTH) 
 AF: 
AC: 
1410
AN: 
2108
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.499 
Heterozygous variant carriers
 0 
 1483 
 2967 
 4450 
 5934 
 7417 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 844 
 1688 
 2532 
 3376 
 4220 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
2606
AN: 
3478
ClinVar
Significance: Benign 
Submissions summary: Benign:5 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not provided    Benign:3 
Jun 29, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Oct 23, 2015
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
not specified    Benign:1 
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Glycogen storage disorder due to hepatic glycogen synthase deficiency    Benign:1 
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.